Lexaria Bioscience Corp. (LEXX)
NASDAQ: LEXX · Real-Time Price · USD
0.6024
+0.0256 (4.44%)
At close: May 13, 2026, 4:00 PM EDT
0.6001
-0.0023 (-0.38%)
After-hours: May 13, 2026, 6:11 PM EDT
Lexaria Bioscience Employees
Lexaria Bioscience had 7 employees as of August 31, 2025. The number of employees did not change compared to the previous year.
Employees
7
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$52,571
Profits / Employee
-$1,361,417
Market Cap
14.93M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Aug 31, 2025 | 7 | 0 | - |
| Aug 31, 2024 | 7 | 2 | 40.00% |
| Aug 31, 2023 | 5 | -2 | -28.57% |
| Aug 31, 2022 | 7 | 1 | 16.67% |
| Aug 31, 2021 | 6 | 2 | 50.00% |
| Aug 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Passage Bio | 24 |
| BioLineRx | 24 |
| IN8bio | 17 |
| Moleculin Biotech | 17 |
| Theriva Biologics | 16 |
| NewcelX | 15 |
| Genenta Science | 9 |
| Cadrenal Therapeutics | 4 |
LEXX News
- 6 days ago - Lexaria Bioscience Releases Second Episode of Investor Video Series - Accesswire
- 8 days ago - Lexaria Bioscience provides update on Human Pilot Study #7 - TheFly
- 8 days ago - Lexaria Updates Progress on Human Study #7 - Accesswire
- 12 days ago - Lexaria Bioscience Launches Ongoing Investor Video Series to Expand Shareholder Communications - TheNewswire
- 14 days ago - Lexaria Bioscience extends material transfer agreement with pharma company - TheFly
- 14 days ago - Material Transfer Agreement Between Pharmaceutical Company and Lexaria is Extended - TheNewswire
- 20 days ago - Lexaria Bioscience launches new study to examine next-gen GLP-1 drugs - TheFly
- 20 days ago - Lexaria Launches New Study to Examine Next-Generation GLP-1 Drugs - TheNewswire